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INTRODUCTION
 The term hypopituitarism denotes the deficiency 
of one or more of the hormones of the anterior or 
posterior pituitary gland whereas, panhypopituita-
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rism is defined as the loss of all the pituitary hor-
mones and the term is often used in clinical prac-
tice to describe patients with deficiency in growth 
hormone (GH), gonadotropins, corticotropin, and 
thyrotropin. The posterior pituitary function may 
remain intact in these patients.1 
 Hypopituitarism is a rare disorder with an esti-
mated incidence of 2.07- 4.2 cases per 100,000 per 
year and a prevalence of 37.5- 45.5 cases per 100,000 
per year with no gender difference reported.2,3 It is 
most commonly caused by pituitary tumors, pitui-
tary surgery or radiotherapy. Other causes include 
pituitary apoplexy, Sheehan’s syndrome, stroke, 
traumatic brain injury and subarachnoid hemor-
rhage. Rarely, infiltrative processes such as lym-
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ABSTRACT
Objective: Data regarding the etiology, clinical and biochemical patterns in hypopituitarism is scant for 
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Conclusions: Non-traumatic hypopituitarism was more common in women, with Sheehan syndrome being 
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common hormonal deficiency. The most commonly reported symptom was weakness.
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phocytic hypophysitis, sarcoidosis and hemochro-
matosis cause hypopituitarism.4 A retrospective 
study of United Kingdom involving 172 adults with 
partial or complete hypopituitarism diagnosed be-
tween 1967 and 1994 were found to have the follow-
ing causes for the pituitary disease: pituitary tumor 
or treatment of the tumor (76%), an extra pituitary 
tumor (13%), unknown cause (8%), sarcoidosis 
(1%) and Sheehan’s syndrome (0.5%).5 In contrast, 
a study from east India reported commonest eti-
ology of hypopituitarism to be pituitary tumors 
(40%), Sheehan’s syndrome (8%) and tuberculosis 
(3%).6 This reflects that Sheehan syndrome is still 
a common cause of hypopituitarism in developing 
countries.7,8 The presentation of any cause hypo-
pituitarism includes progressive loss of pituitary 
hormone secretion. This results in impaired qual-
ity of life, morbidity and mortality.9 The sequence 
of hormonal loss is highly variable, however, the 
usual pattern shows that GH is earliest to be lost. 
The next hormonal axis to be affected is the gonado-
tropins; the Luteinizing Hormone (LH) and Follicle 
Stimulating Hormone (FSH), followed by adreno-
corticotrophic hormone (ACTH) and finally loss of 
thyrotropin (TSH) secretion.10 
 Hypopituitarism is generally difficult to diagnose 
and the diagnosis is often delayed or missed 
because of lack of understanding of this condition. 
To facilitate early recognition, diagnosis and timely 
management of this condition, we aimed to study 
its common clinical and biochemical presentation in 
a tertiary setup of Pakistan, which has never been 
reported before in the literature.
METHODS
Ethics approval: This research has been conducted 
on the human data after institution’s ethical review 
committee approval (ERC number 3043-Med-
ERC-14). 
Data collection: We performed a retrospective 
analysis of patients with hypopituitarism from Jan-
uary 2004 to December 2013 at the Section of Endo-
crinology, Department of Medicine, Aga Khan Uni-
versity Hospital, which is a large tertiary care center 
in Pakistan. It has specialized neurosurgery unit 
and medical records are maintained in the Health 
Information and Management System (HIMS) un-
der Quality Control policy of the hospital. A list 
was generated by HIMS by using the search term 
of hypopituitarism. Patients with hypopituitarism 
secondary to sellar or parasellar tumors and trau-
matic brain injury were excluded. We reviewed the 
specific causes of hypopituitarism from inpatient 
and outpatient medical records, as documented 
by the caring endocrinologists, neurosurgeons and 
obstetricians. Information was recorded using data 
collection sheet and included the demographic and 
clinical parameters. The biochemical profile con-
sists of assessment of anterior pituitary hormones 
function including ACTH, morning cortisol, TSH, 
free thyroxine levels, prolactin, LH, FSH, Testoster-
one, Estradiol, Insulin like growth factor-1 and GH. 
Data was collected by trained medical doctors and 
double checked by principal investigator. 
Statistical analysis: The statistical analysis 
was conducted by using the Statistical package 
for social science SPSS (Release 16.0 standard 
version, copyright © SPSS). A descriptive analysis 
was performed for demographic and clinical 
characteristics and results are presented as mean ± 
standard deviation for quantitative variables and 
numbers (percentages) for qualitative variables.
RESULTS
Demographic & clinical characteristics of 
hypopituitarism patients: During nine years, 
a total of 42 patients were diagnosed to have 
Table-I: Demographic characteristics & clinical 
manifestations of patients with hypopituitarism.
Characteristics No. of Patients (%)
Age
   18-35 5 (11.9)
   36-55 16 (38.1)
   >55  21 (50.0)
Gender 
   Male 5 (11.9)
   Female 37 (88.1)
Duration of Illness 4.4 ± 4.9 years
Decreased Libido  30 (71.4)
Decreased Body Hair  25 (59.5)
Amenorrhea/Oligomenorrhea  33 (91.6)
Diminished sense of well being  40 (95.2)
Weight loss  29 (69.0)
Lethargy  38 (90.5)
Cold Intolerance  20 (47.6)
Decreased Appetite  36 (85.7)
Constipation  12 (28.6)
Facial puffiness  7 (16.7)
Headache  13 (31.0)
Visual disturbance  3 (7.1)
Altered Level of consciousness  20 (47.6)
Seizures  6 (14.3)
Hypotension  12 (28.6)
Anemia  20 (47.6)
Hyponatremia 30 (71.4)
Arrythmias 4 (9.5)
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hypopituitarism other than sellar or parasellar 
tumors and traumatic brain injury. Thirty-seven 
patients (88.1%) were females. Table-I shows 
the demographic and clinical manifestations of 
these patients. Mean age ± standard deviation of 
the participants was 53.8 ± 14.7 years with 50% 
having age greater than 55 years. The median 
duration of experiencing symptoms was 2.7 years 
(interquartile range: 0.72-5.95 years). Sixteen 
patients had secondary infertility and all were 
females; a majority of patients in this group had 
Sheehan’s syndrome (n=8) followed by empty sella 
syndrome (n=3), partial empty sella syndrome 
(n=2), idiopathic cause (n=2) and tuberculoma 
(n=1). Eighteen females (48.6%) reported inability 
to lactate. In our sample, hypopituitarism was 
found to be more prevalent amongst women. Of 
the total sample, Sheehan’s syndrome (n=15) were 
all women, tuberculoma of pituitary gland were 
also found in women only (n=2), out of 10 patients 
having empty sella syndrome, seven were women, 
hypoplastic pituitary gland was found in two 
women and one man. Idiopathic cause was found 
in five patients and all were women. In addition, 
partial empty sella syndrome was found in six 
women and one man.
Etiology & Hormonal profile of hypopituitarism: 
Fig.1 presents the distribution of etiology of 
hypopituitarism in these patients. The most 
common etiology was Sheehan’s syndrome 
(35.7%). Table-II, shows comparison of Sheehan’s 
syndrome with other causes of hypopituitarism 
with no significant difference in demographic, 
clinical and biochemical parameters. Distribution 
of patients with hormone deficiencies and age 
groups is presented in Fig.2 and 3.
Non-traumatic Hypopituitarism
Fig.1: Causes of hypopituitarism in patients presenting to a tertiary care hospital, n (%).
Fig.2: Percentage of patients with documented hormonal 
deficiencies in Sheehan`s Syndrome and others (n=42).
Fig.3: Age distribution of patients with different 
hormonal deficiencies (n= 42).
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Table-II: Differences according to etiology of hypopituitarism.
Characteristics Sheehan’s Syndrome Others P-Value
 N=15 (35.7%) N=27 (64.3%)
Age groups (years)
    18-35 3 (20.0) 2 (7.4) 0.22
    36-55 7 (46.7) 9 (33.3)
    56 and above 5 (33.3) 16 (59.3)
Gender 
    Men 0(0) 5(18.5) 0.07
    Women 15(100) 22(81.5)
Duration of Illness, mean (SD) (months)  42.8 (35.9) 58.6 (69.8) 0.42
Decreased Libido 13 (86.7) 17 (63.0) 0.10
Infertility  8 (53.3) 8 (30.8) 0.15
Decreased Body Hair  10 (66.7) 15 (55.6) 0.48
Diminished sense of well being  15 (100) 25 (92.6) 0.28
Weakness  15 (100) 26 (96.3) 0.45
Hyponatremia  9 (60) 21 (77.8) 0.22
Hypoglycemia  4 (26.7) 2 (7.4) 0.08
Hypotension  6 (40.0) 6 (22.2) 0.22
Eosinophilia  2 (13.3) 3 (11.1) 0.83
Fatigue  14 (93.3) 24 (88.9) 0.63
Weight loss  12 (80.0) 17 (63.0) 0.25
Lethargy  14 (93.3) 24 (88.9) 0.63
Cold intolerance  9 (60.0) 11 (40.7) 0.23
Decreased appetite  14 (93.3) 22 (81.5) 0.29
Constipation  5 (33.3) 7 (25.9) 0.611
Facial Puffiness  3 (20.0) 4 (14.8) 0.66
Bradycardia  0 (0) 1 (3.7) 0.45
Anemia  7 (46.7) 13 (48.1) 0.92
Headache  4 (26.7) 9 (33.3) 0.65
Visual Disturbance  0 (0) 3 (11.1) 0.18
Altered Level of consciousness  10 (66.7) 10 (37.0) 0.06
Seizures  2 (13.3) 4 (14.8) 0.89
Arrhythmia  1 (6.7) 3 (11.1) 0.63
Body Mass Index, mean(SD) 
    Underweight (≤ 18.4) 3 (25.0) 4 (22.2) 0.52
    Acceptable (18.5-22.9) 3 (25.0) 3 (16.7)
    Overweight (23-24.9) 3 (25.0) 2 (11.1)
    Obese (25 and above) 3 (25.0) 9 (50.0)
Gonadotrophic deficiency  14 (93.3) 20 (74.1) 0.12
ACTH deficiency  14 (93.3) 27 (100) 0.17
TSH deficiency  15 (100) 27 (100) -
Growth hormone deficiency  14 (93.3) 26 (96.3) 0.66
Prolactin Deficiency  7 (46.7) 6 (22.2) 0.10
Heart rate, mean(SD) (rates/min) 84.2 (13.1) 76.2 (9.3) 0.04
Blood pressure, systolic, mean(SD) (mmHg) 135.4 (28.2) 123.3 (22.4) 0.16
Blood pressure, diastolic, mean(SD) (mmHg) 73.4 (12.6) 72.6 (10.9) 0.83
Weight, mean(SD) (Kg) 52.5 (12.6) 59.6 (15.5) 0.17
Height, mean(SD) (cm) 153.4 (6.0) 155.8 (7.8) 0.37
†SD: Standard deviation.
Pak J Med Sci     July - August  2019    Vol. 35   No. 4      www.pjms.org.pk     1153
Non-traumatic Hypopituitarism
DISCUSSION
Prevalence of hypopituitarism: A study conducted 
in a tertiary care center in India reports most 
common cause of hypopituitarism to be a non-
functioning pituitary adenoma followed by 
Sheehan’s syndrome (27%).11 As we have excluded 
sellar and parasellar tumors, which remains 
the commonest cause, we found that 35.7% of 
hypopituitarism was attributable to Sheehan’s 
syndrome, which is close to a Turkish study (107 
of 388 patients; 27.6%).12 Sheehan’s syndrome also 
accounted for the cause of hypopituitarism in 41% 
(15/22) of women in our study. This is probably 
because the prevalence of Sheehan syndrome is 
still very common in developing countries, due 
to inadequate availability of obstetric care. In 
contrast the western data reported only 0.5% cases 
of Sheehan’s syndrome causing hypopituitarism in 
one of the study.5 Empty sella syndrome was the 
next most common cause of hypopituitarism in 
our study population (23.8%) which is different to 
the 7.3% frequency reported by Chatterjee et al.6 
We had only five men in our study, all of whom 
had presented with decreased libido, weakness 
and fatigue and decreased appetite, besides 
other complaints. The most common etiology of 
hypopituitarism was empty sella syndrome (80%). 
Around 11.9% cases had idiopathic hypopituitarism 
with almost similar figure reported by Tanriverdi 
et al. (10.6%).12 Hypopituitarism was also reported 
in 20% of a small subset of patients after recovery 
from tuberculous meningitis in a study done in a 
teaching hospital.13
Spectrum of hormonal deficiency: Most common 
hormonal deficiency was found to be TSH with 
100% of the study population being affected, 
followed by hypocortisolism secondary to ACTH 
deficiency (97.6%) and growth hormone deficiency 
(95.2%). Almost a similar study conducted in India 
reported the clinical spectrum of hypopituitarism 
with hypogonadism (97%) as the most common 
abnormality, followed by growth hormone 
deficiency (88.1% of the 42 patients tested), 
hypothyroidism (83.2%), hypoadrenalism (79.6%), 
and diabetes insipidus (13.3%).13
Clinical features of hypopituitarism: Most 
commonly reported symptoms in our study 
populations was weakness (97.6%), diminished 
sense of wellbeing (95.2%) and lethargy (90.5%). 
These symptoms either reflect the manifestation 
of electrolytic disturbances like hyponatremia, 
found in about 71.4% of our study population or 
due to hypothyroidism and adrenal insufficiency. 
An interesting finding of increased hypoglycemia 
in Sheehan’s syndrome compared to other causes 
is speculative, but not significant (p=0.08) in our 
study. Although presentation with hypoglycemia 
is rare, but this is increasingly being reported to 
be due to an acute as well as delayed presentation 
of varying pituitary deficiencies, especially the 
hypothalamus-pituitary-adrenal axis.14-18 Our 
patients with Sheehan’s syndrome also had 
significantly higher heart rate compared to  other 
causes of hypopituitarism (p=0.04), reflecting the 
hemodynamic changes associated with the chronic 
adaptation of cardiovascular system associated 
with adrenal insufficiency well reported in acute as 
well as chronic cases.19-23 Patients in our study were 
all delayed in their diagnosis. However, no studies 
have been done to demonstrate any head-to-head 
comparison regarding circulatory dynamic changes 
in patients with Sheehan’s and other causes of 
hypopituitarism, although such changes are equally 
represented in the later.24-26 
 There may be number of methodological 
limitations associated with a retrospective study 
design, as most of the patients are catered when 
they are extremely symptomatic. Medical record 
reviews are dependent on the content of the medical 
charts and the care with which it was recorded. 
However, considering these limitations, this is the 
only study from one tertiary health care hospital out 
of a population of 207.8 million people in Pakistan. 
We propose to do much larger studies in the future.
CONCLUSIONS
 We conclude that Sheehan’s syndrome is the 
most common cause of hypopituitarism in Pakistan 
after excluding patients of sellar and suprasellar 
tumors. Most common hormonal deficiency was 
TSH and most commonly reported symptoms were 
weakness. Sheehan syndrome can be prevented by 
provision of adequate obstetric care especially in 
patients with low socio-economic status. 
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